Precision Biosciences (DTIL) Operating Margin Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1,211.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 6,993.00 |
| 10 | Precision Biosciences | 171.70 Mn | 70.52 Mn | - | 6,836.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,836.00 |
| Dec 31, 2025 | 15,083.00 |
| Sep 30, 2025 | -15.88 Mn |
| Jun 30, 2025 | -12.08 Mn |
| Mar 31, 2025 | -7.54 Mn |
| Dec 31, 2024 | -340,968.00 |
| Sep 30, 2024 | -364,556.00 |
| Jun 30, 2024 | 1,695.00 |
| Mar 31, 2024 | 9,083.00 |
| Dec 31, 2023 | 5,386.00 |
| Sep 30, 2023 | 25,948.00 |
| Jun 30, 2023 | 302,760.00 |
| Mar 31, 2023 | 24,082.00 |
| Dec 31, 2022 | 22,093.00 |
| Sep 30, 2022 | 25,244.00 |
| Jun 30, 2022 | -33,071.00 |
| Mar 31, 2022 | -46,719.00 |
| Dec 31, 2021 | -15,867.00 |
| Sep 30, 2021 | 36,312.00 |
| Jun 30, 2021 | 67,845.00 |
| Mar 31, 2021 | 48,975.00 |